These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 20623765)

  • 21. Catatonic variants, hyperthermic extrapyramidal reactions, and subtypes of neuroleptic malignant syndrome.
    Lee JW
    Ann Clin Psychiatry; 2007; 19(1):9-16. PubMed ID: 17453656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Zotepine-induced catatonia as a precursor in the progression to neuroleptic malignant syndrome.
    Tsai JH; Yang P; Yen JY; Chen CC; Yang MJ
    Pharmacotherapy; 2005 Aug; 25(8):1156-9. PubMed ID: 16207109
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperthermia caused by drug interactions and adverse reactions.
    Paden MS; Franjic L; Halcomb SE
    Emerg Med Clin North Am; 2013 Nov; 31(4):1035-44. PubMed ID: 24176477
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neuroleptic malignant syndrome following autologous peripheral blood stem cell transplantation.
    Garrido SM; Chauncey TR
    Bone Marrow Transplant; 1998 Feb; 21(4):427-8. PubMed ID: 9509981
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Thermoregulatory dysfunction in neuroleptic malignant syndrome.
    Gurrera RJ; Chang SS
    Biol Psychiatry; 1996 Feb; 39(3):207-12. PubMed ID: 8837982
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuroleptic malignant syndrome secondary to quetiapine.
    Gortney JS; Fagan A; Kissack JC
    Ann Pharmacother; 2009 Apr; 43(4):785-91. PubMed ID: 19299325
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Endovascular cooling in a patient with neuroleptic malignant syndrome.
    Diedler J; Mellado P; Veltkamp R
    J Neurol Sci; 2008 Jan; 264(1-2):163-5. PubMed ID: 17706678
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Malignant neuroleptic syndrome. A review of epidemiology, risk factors, diagnosis, differential diagnosis and pathogenesis of MNS].
    Andreassen MD; Pedersen S
    Ugeskr Laeger; 2000 Mar; 162(10):1366-70. PubMed ID: 10745673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. General anesthesia after neuroleptic malignant syndrome.
    Lotstra F; Linkowski P; Mendlewicz J
    Biol Psychiatry; 1983 Feb; 18(2):243-7. PubMed ID: 6131703
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Neuroleptic malignant syndrome: observations on altered consciousness.
    Deuschl G; Oepen G; Hermle L; Kindt H
    Pharmacopsychiatry; 1987 Jul; 20(4):168-70. PubMed ID: 3615574
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Case study: neuroleptic malignant syndrome without pyrexia.
    Hynes AF; Vickar EL
    J Am Acad Child Adolesc Psychiatry; 1996 Jul; 35(7):959-62. PubMed ID: 8768358
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Neuroleptic malignant syndrome, syndrome malin].
    Takahashi A; Todoroki J; Murasaki M
    Nihon Rinsho; 1996 Mar; 54(3):839-44. PubMed ID: 8904246
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quetiapine-induced neuroleptic malignant syndrome in dementia with Lewy bodies: a case report.
    Kobayashi A; Kawanishi C; Matsumura T; Kato D; Furukawa R; Kishida I; Hirayasu Y
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Aug; 30(6):1170-2. PubMed ID: 16682107
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Neuroleptic malignant syndrome.
    Paul GE; Landers DF; Newman T
    Nebr Med J; 1990 Mar; 75(3):46-9; discussion 49-50. PubMed ID: 2179748
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [A study of neuroleptic malignant syndrome in the presenium and senium].
    Suzuki I; Honma H; Watanabe N; Matsubara S; Koyama T
    Seishin Shinkeigaku Zasshi; 1998; 100(6):387-97. PubMed ID: 9745353
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The evaluation and management of patients with neuroleptic malignant syndrome.
    Bhanushali MJ; Tuite PJ
    Neurol Clin; 2004 May; 22(2):389-411. PubMed ID: 15062519
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Precautionary measures reduce risk of definite neuroleptic malignant syndrome in newly typical neuroleptic-treated schizophrenia inpatients.
    Shiloh R; Valevski A; Bodinger L; Misgav S; Aizenberg D; Dorfman-Etrog P; Weizman A; Munitz H
    Int Clin Psychopharmacol; 2003 May; 18(3):147-9. PubMed ID: 12702893
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pharmacological study of veratrine-induced hyperthermia in the rat: a model of neuroleptic malignant syndrome.
    Kato T; Yamawaki S
    Hiroshima J Med Sci; 1989 Dec; 38(4):173-81. PubMed ID: 2637245
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hyperthermia and heatstroke.
    Simon HB
    Hosp Pract (Off Ed); 1994 Aug; 29(8):65-8, 73, 78-80. PubMed ID: 7914522
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Neuroleptic malignant syndrome after 30 years treatment with clozapine: a rarely seen differential diagnosis on intensive care units].
    Franzen D; Burkhard J; Corti N; Schüpbach D; Fontanel D; Stäubli M
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2006 Feb; 41(2):125-7. PubMed ID: 16493563
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.